AstraZeneca Near Decision on Suicide-Linked Drug, CEO Says – Bloomberg
AstraZeneca Near Decision on Suicide-Linked Drug, CEO SaysBloombergAstraZeneca Plc will decide in a “few weeks” whether to pursue independently a drug for psoriasis after its partner dropped out of the project, said Pascal Soriot, chief executive officer of the U.K. Drug company. Amgen Inc. Terminated the development …and more »
[monetize id=”1″]
[monetize id=”2″]
New Psoriasis Drug Completely Clears Skin in Many Patients – Newsmax
Latin PostNew Psoriasis Drug Completely Clears Skin in Many PatientsNewsmaxPsoriasis is a chronic skin condition characterized by flaking, inflammation, and thick, white, silvery, or red patches of skin. It is estimated that 7.5 million Americans suffer from psoriasis, making it the most common autoimmune disorder in the U.S.New Drug Ixekizumab Can Clear All Psoriasis SymptomsScience 2.0New Psoriasis Medication Shows Fast ImprovementLatin PostPsoriasis 'miracle' drug provides hope to many sufferers of the skin conditionTimes GazetteNewswise (press release) -News-Medical.net -NH Voiceall 57 news articles »
